[1] Van buskirk A M,Adams P W,Orose G C.Nonradioactive alternative to clnical mixed lymphocyte reaction[J].Hum Immumol,1995,43(1):38-44.
[2] Mouria M,Gukovskaya A S,Jung Y,Buechler P,Hines O J,Reber H A and Pandol S J.Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis[J].Int J Cancer,2002,10:761-769.
[3] Morgan R A,Dudley M E,Wunderlich J R,Hughes M S,Yang J C,Sherry R M,Royal R E,Topalian S L,Kammula U S,Restifo N P,Zhili Zheng,Azam Nahvi C R,de Vries,Rogers-Freezer L J,Mavroukis S A and Rosenberg S A.Cancer regression in patients after transfer of genetically engineered lymphocytes[J].Science,2006;314:126-129.
[4] Melief C J,Kast W M.T-cell immunotherapy of tumors by adoptive transfer of cytotoxic Tlymphocytes and by vaccination with minimal essential epitopes [J].Immunol.Rev,1995,145:167-177.
[5] Tey S K,Bollard C M,Heslop H E,Adoptive T-cell transfer in cancer immunotherapy[J].Immunol.Cell Biol,2006,4:281-289.
[6] 胡丽彩,邱曙东,黄树林.TCRVβ7.1基因修饰T细胞对乳腺癌细胞杀伤作用的研究[J].中国免疫学杂志,2003,19(2):97-99.
[7] Kessels H W,Wolkers M C,van den Boom.Immunotherapy through TCR gene transfer[J].Nat.Immunol,2001,2:957-961.